Can melatonin (MLT) 5 mg be started in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Melatonin 5 mg Use in Adults

Melatonin 5 mg is not recommended as a treatment for general insomnia in adults, though it may be considered for specific circadian rhythm disorders such as Delayed Sleep-Wake Phase Disorder (DSWPD). 1, 2

General Recommendations for Insomnia

  • The American Academy of Sleep Medicine (AASM) explicitly suggests that clinicians not use melatonin as a treatment for sleep onset or maintenance insomnia in adults 1
  • This recommendation is based on trials of 2 mg doses of melatonin, which showed insufficient evidence of clinical benefit 1
  • Cognitive behavioral therapy for insomnia (CBT-I) is the preferred first-line approach for both sleep onset and maintenance insomnia 2

Specific Uses of Melatonin 5 mg in Adults

  • For adults with Delayed Sleep-Wake Phase Disorder (DSWPD), 5 mg melatonin timed between 19:00-21:00 for 28 days has shown some benefit 1
  • In studies of adults with DSWPD, 5 mg melatonin decreased sleep latency by 37-43 minutes and increased total sleep time by 41-56 minutes 1
  • The AASM suggests melatonin for DSWPD with a "WEAK FOR" recommendation, indicating benefits likely outweigh harms but many patients might choose not to use this treatment 1

Dosing Considerations

  • Clinical studies have used various doses ranging from 0.5 mg to 10 mg in adults 3, 4
  • For general adult use, effective doses typically range from 1-5 mg 3
  • For older adults (>55 years), doses between 1-6 mg appear effective for improving sleep 4, 5
  • A recent study found that 5 mg significantly increased sleep efficiency during both biological day and night in older adults, while 0.3 mg only improved daytime sleep 5

Safety Considerations

  • Short-term side effects of melatonin at doses of 5 mg or less are generally mild 3, 6
  • Common side effects include daytime sleepiness 6
  • The benefits/harms ratio remains uncertain, as long-term safety data (>6 months) are lacking 6
  • Potential concerns include:
    • Interactions with other medications (largely unexplored) 6
    • Effects on reproductive function (theoretical concern based on animal studies) 6

Clinical Decision Algorithm

  1. For general insomnia in adults:

    • First consider CBT-I or FDA-approved medications (eszopiclone, zolpidem, temazepam) 1, 2
    • Melatonin 5 mg is not recommended 1
  2. For adults with DSWPD:

    • Consider melatonin 5 mg taken between 19:00-21:00 for 4 weeks 1
    • Monitor for improvement in sleep onset and total sleep time 1
  3. For older adults (>55 years) with sleep difficulties:

    • Consider melatonin 1-6 mg, with 5 mg showing efficacy in recent research 4, 5
    • Take 30 minutes before desired bedtime 5

Common Pitfalls

  • Using melatonin as first-line therapy for general insomnia when evidence doesn't support this practice 1, 2
  • Failing to distinguish between general insomnia and circadian rhythm disorders, where melatonin may have different efficacy 1
  • Not considering timing of administration, which is critical for effectiveness in circadian disorders 1
  • Assuming that higher doses are always more effective - some studies show efficacy at lower doses with fewer side effects 4, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Sleep Onset and Maintenance Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety of melatonin in long-term use (?).

Journal of biological rhythms, 1997

Research

Melatonin in elderly patients with insomnia. A systematic review.

Zeitschrift fur Gerontologie und Geriatrie, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.